UK trial regulation may support haemophilia treatment access
The new MHRA scheme helps to reduce the time it takes for the lowest-risk clinical trials to commence, while maintaining patient safety.
Source: europeanpharmaceuticalreview.com
Stay updated with breaking news from Notification Scheme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new MHRA scheme helps to reduce the time it takes for the lowest-risk clinical trials to commence, while maintaining patient safety.
As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape. To help companies and...
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.